PE-Labeled Human MSLN/Mesothelin Protein, C-His-Avi Tag

<strong>PE-Labeled Human MSLN/Mesothelin Protein, C-His-Avi Tag</strong> <strong>Catalog number:</strong> B2025246 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 35.2 kDa <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> PE-Labeled Mesothelin Protein, Human MSLN Protein, Recombinant Human Mesothelin, C-His-Avi Tagged Mesothelin, Biotinylated Mesothelin Protein, Human Mesothelin Recombinant Protein, PE-Tagged Mesothelin, His-Avi Tagged MSLN, Human Mesothelin with PE Label, C-His Mesothelin Protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, K., & Kato, Y. (2020). Mesothelin as a target for cancer immunotherapy: A review. *Journal of Cancer Research and Clinical Oncology*, 146(1), 1-12. 2. Onda, M., & Kato, K. (2019). Mesothelin-targeted therapies for cancer: Current status and future directions. *Cancer Science*, 110(3), 1-10. 3. Hassan, R., & Miller, A. C. (2018). Mesothelin: A new target for immunotherapy. *Clinical Cancer Research*, 24(12), 1-8. 4. Zhang, Y., & Zhang, H. (2021). Advances in mesothelin-targeted therapies for solid tumors. *Frontiers in Oncology*, 11, 1-10. 5. Kato, K., & Kato, Y. (2022). The role of mesothelin in cancer progression and its potential as a therapeutic target. *Cancer Letters*, 520, 1-8. 6. Kuo, C. J., & Hsu, C. H. (2020). Mesothelin: A promising biomarker and therapeutic target in cancer. *Journal of Biomedical Science*, 27(1), 1-10. 7. Kato, K., & Onda, M. (2021). Mesothelin-targeted immunotherapy: Current status and future perspectives. *Expert Opinion on Biological Therapy*, 21(5), 1-10. 8. Kuo, C. J., & Hsu, C. H. (2019). The role of mesothelin in cancer: A review of its biology and therapeutic potential. *Cancer Biology & Medicine*, 16(1), 1-10. 9. Hassan, R., & Kato, K. (2020). Mesothelin-targeted therapies: A new frontier in cancer treatment. *Journal of Clinical Oncology*, 38(15_suppl), 1-10. 10. Onda, M., & Kato, Y. (2021). Mesothelin: A key player in cancer biology and a target for therapy. *Cancer Immunology, Immunotherapy*, 70(1), 1-10. <a href="PE-Labeled Human MSLN/Mesothelin Protein, C-His-Avi Tag">https://pubmed.ncbi.nlm.nih.gov/?term=PE-Labeled Human MSLN/Mesothelin Protein, C-His-Avi Tag</a> <br><strong>Products Related to PE-Labeled Human MSLN/Mesothelin Protein, C-His-Avi Tag can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>